Acknowledgements We acknowledge Partec GmbH (Mnster, Germany) for continuous technical support
Phase 2 clinical trials showed some positive outcomes, but these were not sufficiently significant over a treatment period of 7-10 days, leading to the halt of development [11, 12]
PT-141 (Bremelanotide) Injections PT-141 is a unique therapy that works at the neurological level to treat low sexual desire (HSDD)
Side Effects Injection Site Reactions : Pain, redness, or itching at the injection site are typical adverse effects
Losing muscle is one of the biggest mistakes people can make when trying to improve their health
They are documented patterns in self-reported community sources, included to show how users have described handling adverse effects in the complete absence of trial-defined safety data